| Contribution of BRCA1 and BRCA2 germline mutations to early Algerian breast cancer S Henouda, A Bensalem, R Reggad, N Serrar, L Rouabah, P Pujol Disease Markers 2016 (1), 7869095, 2016 | 28 | 2016 |
| Impact of the COVID-19 pandemic on oncologists: Results of an international study AR Jazieh, AK Coutinho, AA Bensalem, AA Alsharm, H Errihani, ... JCO Global Oncology 7, 242-252, 2021 | 20 | 2021 |
| Epidemiology of breast cancer in women based on diagnosis data from oncologists and senologists in Algeria F Smaili, A Boudjella, A Dib, S Braikia, H Zidane, R Reggad, A Bendib, ... Cancer Treatment and Research Communications 25, 100220, 2020 | 16 | 2020 |
| Burnout in oncology: magnitude, risk factors and screening among professionals from Middle East and North Africa (BOMENA study) A Abusanad, A Bensalem, E Shash, L Mula‐Hussain, Z Benbrahim, ... Psycho‐Oncology 30 (5), 736-746, 2021 | 14 | 2021 |
| Épidémiologie des cancers du sein de la femme jeune en Afrique du Nord Y Belkacémi, H Boussen, M Hamdi-Cherif, A Benider, H Errihani, H Mrabti, ... 32° Journées de la Société Française de Sénologie et de Pathologie Mammaire …, 2010 | 13 | 2010 |
| Neoadjuvant endocrine therapy with or without palbociclib in low-risk patients: a phase III randomized double-blind SAFIA trial K Alsaleh, H Al Zahwahry, A Bounedjar, M Oukkal, A Saadeddine, ... Journal of cancer research and clinical oncology 149 (9), 6171-6179, 2023 | 12 | 2023 |
| Early onset breast cancer: differences in risk factors, tumor phenotype, and genotype between North African and South European women C Corsini, S Henouda, DB Nejima, H Bertet, A Toledano, H Boussen, ... Breast cancer research and treatment 166, 631-639, 2017 | 9 | 2017 |
| Response to induction neoadjuvant hormonal therapy using upfront 21-gene breast recurrence score assay—results from the SAFIA phase III trial K AlSaleh, H Al Zahwahry, A Bounedjar, M Oukkal, A Saadeddine, ... JCO Global Oncology 7, 811-819, 2021 | 8 | 2021 |
| Incidence of lung cancer in males and females in Algeria: the lung cancer registry in Algeria (LuCaReAl) A Bounedjar, R Benkali, L Badoui, M Abada, A Moumeni, A Marouani, ... Cancer Epidemiology 69, 101799, 2020 | 7 | 2020 |
| Prevalence and risk factors of burnout among female oncologists from the middle east and north africa A Abusanad, A Bensalem, E Shash, L Mula-Hussain, Z Benbrahim, ... Frontiers in Psychology 13, 845024, 2022 | 6 | 2022 |
| Predictors of poor precautionary practices towards COVID-19 among cancer patients AR Jazieh, AA Bensalem, A Bounedjar, Z Benbrahim, MO Alorabi, ... Future Oncology 17 (35), 4871-4882, 2021 | 6 | 2021 |
| Final result for SAFIA trial for neoadjuvant palbociclib in patients with operable luminal breast cancer responding to fulvestrant. KA Al-Saleh, HM El Zawahry, A Bounedjar, M Oukkal, A Saadeddin, ... Journal of Clinical Oncology 40 (16_suppl), 596-596, 2022 | 3 | 2022 |
| 1687P Oncologists knowledge, attitude and practice in COVID-19 pandemic and its negative impact on them: an international study AR Jazieh, AK Coutinho, A Bensalem, AA Alsharm, H Errihani, ... Annals of Oncology 31, S998, 2020 | 3 | 2020 |
| 1579P burnout among oncology professionals in the middle East and North Africa (Mena) AM Abusanad, A Bensalem, E Shash, LYI Mula-Hussain, Z Benbrahim, ... Annals of Oncology 31, S959, 2020 | 3 | 2020 |
| Prediction of response to neoadjuvant hormonal therapy (NAHT) using upfront oncotype Dx recurrence score (RS): Results from the SAFIA phase III trial. KA Al-Saleh, A Bounedjar, M Oukkal, H Mahfouf, K Bouzid, A Bensalem, ... Journal of Clinical Oncology 38 (15_suppl), 594-594, 2020 | 3 | 2020 |
| Breast Carcinoma in Younger Algerian Eastern Women: Epidemiological Profile in Series of 135 Cases S Henouda, A Bensalem, L Rouabah Age 15, 30.4, 2015 | 3 | 2015 |
| 1717P behavioral practices of cancer patients during COVID-19 pandemic: a middle east and north Africa study AR Jazieh, Z Benbrahim, S Al-Sukhun, AM Abusanad, MO Alorabi, ... Annals of Oncology 31, S1009, 2020 | 2 | 2020 |
| A multicentre, international neoadjuvant (NA), randomized, double-blind phase III trial comparing fulvestrant to a combination of fulvestrant and palbociclib in patients with … JMA Nabholtz, KA Alsaleh, A Bounedjar, M Oukkal, HM El-Zawahry, ... Annals of Oncology 30, v67, 2019 | 2 | 2019 |
| Gemcitabine/paclitaxel compared to gemcitabine/vinorelbine in metastatic breast cancer: An interim analysis A Bensalem, K Bouzid Journal of Clinical Oncology 25 (18_suppl), 1097-1097, 2007 | 2 | 2007 |
| Breast carcinoma in women 40years of age or younger: epidemiologic profile in series of 135cases from Algerian Eastern S Henouda, A Bensalem, L Rouabah World J Pharm Res 4, 38-56, 2015 | 1 | 2015 |
